Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Ocugen, Inc. - Common Stock (NQ:OCGN)

1.090 -0.030 (-2.68%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 25, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Ocugen, Inc. - Common Stock

< Previous 1 2
...
12 13 14 15 16 17 18 19 20
...
34 35 Next >
State Street Just Bought Ocugen (OCGN) Stock. Here’s Why.
OCGN stock has declined by over 90% in the past five years. However, that hasn't stopped State Street from more than doubling its position. 
Via InvestorPlace
Why Is Lixte Biotechnology (LIXT) Stock Up Today?
Lixte Biotechnology (LIXT) stock is rocketing higher on Tuesday after the company revealed pre-clinical results for one of its treatments. 
Via InvestorPlace
Why Is Ocugen (OCGN) Stock Down Today?
Shares of OCGN stock are trading lower after the FDA announced that it had placed a clinical hold on Covaxin. Here's what you should know. 
Via InvestorPlace
FDA Places Clinical Hold On Ocugen's Late-Stage COVID-19 Vaccine Trial
The  
Via Benzinga
Here's Why Ocugen Shares Are Falling
Ocugen Inc (NASDAQ: OCGN) shares are trading lower by 5.86% to $2.73 during Tuesday's pre-market session after the company announced that it was informed by the FDA that... 
Via Benzinga
What the WHO Snub Means For Ocugen Stock Investors?
Add the World Health Organization's suspension of Covaxin to the list of troubles that are weighing down OCGN stock. 
Via InvestorPlace
Why Is Ocugen (OCGN) Stock Up 10% Today?
Sometimes, improved investor sentiment and a revamped website is enough of a catalyst to take something like OCGN stock on a 10% ride higher. 
Via InvestorPlace
Ocugen Is Two Strikes in With a Third in the Books
Ocugen failed to get energency use authorization for pediatric use of Covaxin. OCGN stock has tanked as a result. 
Via InvestorPlace
Why Is Ocugen (OCGN) Stock Down Today?
Shares of OCGN stock are in the red after the company's Covaxin Covid-19 vaccine was declined EUA by the FDA. Here's what you should know. 
Via InvestorPlace
Why Ocugen Shares Are Falling
Ocugen Inc (NASDAQ:OCGN) shares are trading lower by 22.8%... 
Via Benzinga
Read Why Did WHO Suspend UN Supply of Bharat Biotech's Covaxin COVID-19 Vaccine
 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
If you're looking for the biggest pre-market stock movers for Monday, we've got you covered with a list of gainers and losers for today. 
Via InvestorPlace
26 Stocks Moving in Monday's Pre-Market Session
Gainers SPI Energy Co., Ltd. (NASDAQ: SPI) rose 36.3% to $3.87 in pre-market trading after reporting record revenue of $162 million for 2021. Twitter, Inc. (NYSE: TWTR) rose... 
Via Benzinga
These Were The 20 Most Searched Tickers On Benzinga In The First Quarter: Did Your Favorite Stock Make The List?
The first three months of 2022 are in the books, bringing the first quarter to a close. Investors were faced with many macro events, including rising inflation and the war in Ukraine. Benzinga was a... 
Via Benzinga
It’s Time to Get Clinical, Not Cynical, With Ocugen Stock
The selling pressure on OCGN stock has been as heavy as a rock, but worried shareholders should celebrate Ocugen's breakthrough moments. 
Via InvestorPlace
The Biggest Reasons to Avoid Ocugen for Now
Ocugen was one of the hottest stocks on the market. OCGN Stock soared from 18 cents to $17.6 back to about $2.5. Now, I wouldn’t touch it. 
Via InvestorPlace
Why Is Ocugen (OCGN) Stock Up Today?
Biotechnology company Ocugen is grabbing headlines today after jumping more than 15%. Is OCGN stock making a comeback? 
Via InvestorPlace
3 Market ETF Stocks to Buy This Week on Fed Jitters
The bears have two major tailwinds and the Fed is one. Here are 3 ETF stocks to buy into a potential relief rally after the event blows over. 
Via InvestorPlace
Is Sweetgreen Stock a Buy After Earnings? 3 Analysts Weigh In on SG.
Sweetgreen (SG) stock is rising as we check it with analysts following the fast-casual restaurants' most recent earnings report. 
Via InvestorPlace
43 Stocks Moving In Friday's Mid-Day Session
Gainers VEON Ltd. (NASDAQ: VEON) rose 45.6% to $0.3830 after dropping 41% on Thursday. Indonesia Energy Corporation Limited (NASDAQ: INDO) shares climbed 45.2% to $29.33 after... 
Via Benzinga
68 Biggest Movers From Friday
Gainers Indonesia Energy Corporation Limited (NASDAQ: INDO) shares jumped 101.8% to close at $40.77 on Friday after jumping 39% on Thursday. Mexco Energy Corporation (NYSE: MXC... 
Via Benzinga
Is BABA Stock a Buy? 3 Analysts Weigh In on Alibaba.
Alibaba (BABA) stock is in the news lately with the company's shares slipping and we're seeing what experts have to say. 
Via InvestorPlace
Recap: Ocugen Q4 Earnings
Ocugen (NASDAQ:OCGN) reported its Q4 earnings results on Friday, February 25, 2022 at 07:30 AM. Here's what investors need to know about the announcement. Also check... 
Via Benzinga
Ocugen Latest News: What OCGN Stock Investors Need to Know About the FDA’s Covaxin Rejection
Ocugen (OCGN) stock is falling hard on Friday after the FDA rejected its Emergency Use Authorization request for Covaxin. 
Via InvestorPlace
Mid-Morning Market Update: Markets Open Lower; U.S. Economy Adds 678,000 Jobs
U.S. stocks opened on a downbeat note this morning following the release of weekly jobless claims data. Following the market opening Friday, the Dow traded down 1.29% to 33,360.18... 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Statera BioPharma (NASDAQ:STAB) stock rose 23.6% to $0.9 during Friday's pre-market session. The company's market cap stands at $32.4 million. InVivo... 
Via Benzinga
FDA Denies Pediatric EUA To Ocugen For Bharat Biotech's COVID-19 Vaccine Covaxin
The FDA has declined to issue an Emergency Use Authorization (EUA) for Covaxin for active immunization to prevent COVID-19 in individuals 2 to 18 years of age. Ocugen... 
Via Benzinga
The Daily Biotech Pulse: Ocugen Faces Regulatory Setback, vTv CEO Quits, Biogen-Eisai Make Headway With Second Alzheimer's Antibody Treatment In Japan
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Merck's Keytruda Evaluated In Combination With Microbiome Therapeutic In... 
Via Benzinga
Looking Into Ocugen Inc's Recent Short Interest
Ocugen Inc's (NASDAQ:OCGN) short percent of float has risen 8.35% since its last report. The company recently reported that it has 54.94 million shares sold short, which is 30.23... 
Via Benzinga
Earnings Scheduled For February 25, 2022
Companies Reporting Before The Bell • ACM Research (NASDAQ:ACMR) is estimated to report quarterly earnings at $0.64 per share on revenue of $89.53 million. •... 
Via Benzinga
< Previous 1 2
...
12 13 14 15 16 17 18 19 20
...
34 35 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.